menu search

kinarus therapeutics signed chf1.5 million convertible loan agreement with chaodian (hangzhou) investment management

Under the terms of the loan agreement, CDIM grants a subordinated loan in the amount of CHF 1.5 million to kin...

May 11, 2023, 5:29 am

Inhibikase therapeutics to report first quarter financial results on may 15, 2023

BOSTON and ATLANTA , May 8, 2023 /PRNewswire/ -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) ("Inhibikase" or "Company"), a clinical-stage pharmaceuti...

May 8, 2023, 8:05 am

Renaissancere holdings ltd. (rnr) q1 2023 earnings call transcript

RenaissanceRe Holdings Ltd. (NYSE:RNR ) Q1 2023 Earnings Conference Call May 3, 2023 11:00 AM ET Company Participants Keith McCue - SVP, Finance and I...

May 7, 2023, 8:31 am

kinaxis inc. (kxscf) q1 2023 earnings call transcript

kinaxis Inc. (OTCPK:KXSCF) Q1 2023 Results Conference Call May 4, 2023 8:30 AM ET Company Participants ...

May 6, 2023, 6:33 pm

Lantheus holdings, inc. (lnth) q1 2023 earnings call transcript

Lantheus Holdings, Inc. (NASDAQ:LNTH ) Q1 2023 Results Conference Call May 4, 2023 8:00 AM ET Company Participants Mark ...

May 4, 2023, 7:06 pm

Prophase labs’ linebacker-1 cancer therapeutic shows promising mechanisms of action as both a mono-therapy and co-therapy in preclinical studies attacking a range of hard-to-treat cancers, including l

Garden City, NY, May 03, 2023 (GLOBE NEWSWIRE) — ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase”), a next-generation biotech, genomics and diagno...

May 3, 2023, 12:30 pm

Panthera resources partner dfr gold completes first phase of drilling at cascades

Panthera Resources PLC (AIM:PAT) said its Burkina Faso joint venture partner DFR Gold has completed pha...

May 2, 2023, 4:20 am

Ideaya biosciences shares jump on melanoma interim trial results

IDEAYA Biosciences shares jumped after the company posted additional positive interim results from its Phase 2 clinical trial evaluating its darovaser...

April 24, 2023, 12:27 pm

Inhibikase therapeutics to present at the 2023 planet microcap showcase

BOSTON and ATLANTA , April 21, 2023 /PRNewswire/ -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) ("Inhibikase" or "Company"), a clinical-stage pharmace...

April 21, 2023, 8:30 am

Forty dead in attack on army and volunteer defence forces in north burkina faso

OUAGADOUGOU (Reuters) – Unidentified assailants killed 40 people and wounded 33 others in an attack on the army and volunteer defence forces in nort...

April 16, 2023, 2:03 pm

Aptose to participate in canaccord genuity's 2023 horizons in oncology virtual conference

SAN DIEGO and TORONTO, April 10, 2023 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a cli...

April 10, 2023, 4:01 pm

Retail traders 'truly trust' apple and microsoft, says ig north america ceo jj kinahan

JJ kinahan, IG North America CEO, joins 'Squawk Box' to discuss the stocks that will lead the tech sect...

March 31, 2023, 7:55 am

Aptose biosciences announces q4 and fy 2022 results

Aptose Biosciences (NASDAQ: APTO, TSX: APS), a clinical-stage precision oncology company developing highly differentiated oral ...

March 24, 2023, 2:20 pm

Inhibikase therapeutics to report fourth quarter and full-year 2022 financial results on march 31, 2023

BOSTON and ATLANTA , March 23, 2023 /PRNewswire/ -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) ("Inhibikase" or "Company"), a clinical-stage pharmac...

March 23, 2023, 5:15 pm

Nuvalent to present alkove-1 trial in progress poster for nvl-655 at the european lung cancer congress (elcc 2023)

CAMBRIDGE, Mass. , March 23, 2023 /PRNewswire/ -- Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating preci...

March 23, 2023, 6:30 am

Deciphera pharmaceuticals: intrigue phase 3 shows substantial benefit

Deciphera has a strong portfolio of investigational kinase inhibitors, including ripretinib, vimseltini...

March 18, 2023, 5:21 am

Nuvalent to present new preclinical data on alk-selective inhibitor nvl-655 at aacr annual meeting 2023

CAMBRIDGE, Mass. , March 14, 2023 /PRNewswire/ -- Nuvalent, Inc. (Nasdaq: NUVL), a clinical-stage biopharmaceutical company focused on creating preci...

March 14, 2023, 5:59 pm

kinaxis' accelerated growth continues to attract analyst attention but retail investors fail to take

Shares of kinaxis (CA:KXS , US:KXSCF), an Ottawa-based supply chain software company, gained 6% in the...

March 10, 2023, 10:23 pm

Aptose to report fourth quarter and full year 2022 financial results and hold conference call on thursday, march 23, 2023

SAN DIEGO and TORONTO, March 09, 2023 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (Nasdaq: APTO; TSX: APS), a clinical-stage precision oncology compan...

March 9, 2023, 4:05 pm

Ukrainians say they were pressured to register babies as russian during occupation

By Rod Nickel and Leonardo Benassatto KHERSON, Ukraine (Reuters) – The moment her grand-daughter was born, Olha Lu...

March 3, 2023, 11:22 am


Search within

Pages Search Results: